SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $2.13M invested in Scinai Immunotherapeutics in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$129K

Top Sellers

1
-$15K
2
-$7.47K
3
-$1.43K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.71M
2
$129K
3
$119K
4
$81K
5
$52K
6
$14K
7
$12K
8
$4K
9
$4K
10
$2K
11
–